Oral route gets the highest priority for thedelivery of the drug as well as better patient compliance incase of self delivery dosage formulation. The aim ofpresent investigation was undertaken with the objective offormulating sustain release formulation of Itopridehydrochloride for oral drug delivery. Itopride hydrochlorideis highly water soluble prokinetic drug.Hydroxypropylmethylcellulose K4M (lower viscositygrade) and K100M (higher viscosity grade) were used as amatrix forming agents to control the release of drug. HPMCK4M and HPMC K100M were used individually as well asin combination with different proportion in the preparationof the Sustained release formulation. 32 factorial designswere applied to the polymer concentration that affect...
The ultimate aim of the present study was to develop sustained release (SR) tablets of Donepezil Hyd...
Metoclopramide Hydrochloride (MCP), has a short half-life. In order to maintain therapeutic levels i...
Objective: Cisapride is a novel prokinetic agent is best candidate for GERD. Cisapride 20 mg can be ...
Objectives: The tablets were prepared by wet granulation method using polyethylene oxide, which was ...
AbstractThe objective of this present investigation was to develop and formulate sustained release (...
A sustained-release tablet formulation should ideally have a proper release profile insensitive to m...
Objective: Itopride Hydrochloride (ITO) is a prokinetic agent commonly used for the treatment of gas...
The aim of current research was to formulate floating tablets of Itopride hydrochloride using an eff...
Purpose: To formulate sustained-release (SR) matrix tablets of tizanidine hydrochloride (THC) and to...
Among the various routes of drug delivery, oral route is the most preferred route. But conventional ...
Objective: The purpose of present study was to formulate oral sustained release matrix tablet of met...
Oral sustained release (SR) products provide an advantage over conventional dosage forms by optimizi...
The main aim of this investigation was to develop a sustained release matrix tablets of Tramadol HCl...
Objective: In situ gels are suitable to overcome problems of immediate release and short gastrointes...
AbstractMetoclopramide hydrochloride (MCP) is commonly used for the management of gastrointestinal d...
The ultimate aim of the present study was to develop sustained release (SR) tablets of Donepezil Hyd...
Metoclopramide Hydrochloride (MCP), has a short half-life. In order to maintain therapeutic levels i...
Objective: Cisapride is a novel prokinetic agent is best candidate for GERD. Cisapride 20 mg can be ...
Objectives: The tablets were prepared by wet granulation method using polyethylene oxide, which was ...
AbstractThe objective of this present investigation was to develop and formulate sustained release (...
A sustained-release tablet formulation should ideally have a proper release profile insensitive to m...
Objective: Itopride Hydrochloride (ITO) is a prokinetic agent commonly used for the treatment of gas...
The aim of current research was to formulate floating tablets of Itopride hydrochloride using an eff...
Purpose: To formulate sustained-release (SR) matrix tablets of tizanidine hydrochloride (THC) and to...
Among the various routes of drug delivery, oral route is the most preferred route. But conventional ...
Objective: The purpose of present study was to formulate oral sustained release matrix tablet of met...
Oral sustained release (SR) products provide an advantage over conventional dosage forms by optimizi...
The main aim of this investigation was to develop a sustained release matrix tablets of Tramadol HCl...
Objective: In situ gels are suitable to overcome problems of immediate release and short gastrointes...
AbstractMetoclopramide hydrochloride (MCP) is commonly used for the management of gastrointestinal d...
The ultimate aim of the present study was to develop sustained release (SR) tablets of Donepezil Hyd...
Metoclopramide Hydrochloride (MCP), has a short half-life. In order to maintain therapeutic levels i...
Objective: Cisapride is a novel prokinetic agent is best candidate for GERD. Cisapride 20 mg can be ...